Personalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD Patients
NCT: NCT06350617 · RECRUITING
Brief Summary
The objective of this study was to determine the effects of protocols of repetitive transcranial magnetic stimulation (rTMS) therapy based on the functional reserve of each patient with Parkinson's disease, compared to conventional high-frequency rTMS therapy on bilateral primary motor cortex (M1). Investigators hypothesized that the functional reserve of each patient with Parkinson's disease will be different, and therefore an appropriate simulating target for rTMS therapy is needed. In addition, this approach could be more effective compared to conventional protocols applied to patient with Parkinson's disease regardless of their severity, predicted mechanism of motor function recovery, or functional reserves.
Frequently Asked Questions
What is Personalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD Patients?
Personalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD Patients is a clinical trial registered under NCT06350617. Current status: RECRUITING.
What is the status of NCT06350617?
The current status of NCT06350617 (Personalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD Patients) is: RECRUITING.
When did Personalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD Patients start?
Personalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD Patients started on 2024-02-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.